Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus

Creative Commons License

Karatoprak C., Kilicarslan R., Cakirca M., Aydin S., OZKAN T., KOCAMAN O., ...More

BEZMIALEM SCIENCE, vol.6, no.1, pp.1-5, 2018 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 6 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.14235/bs.2018.1050
  • Journal Name: BEZMIALEM SCIENCE
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1-5
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Objective: This study investigated how vildagliptin (a di-peptidyl peptidase 4 inhibitor) affects portal vein pressure and hepatosteatosis in patients with type 2 diabetes mellitus.